Everest Medicines Limited
Everest Medicines Limited, a biopharmaceutical company, engages in discovery, licensing, clinical development, and commercialization of therapies to address critical unmet medical needs in Greater China and other Asia Pacific markets. Its pipeline produc…
Biotechnology
CN, Shanghai [HQ]
1952.HK/Financial Reporting
Income Statements
Profit & Loss · 6 Statements · From 2023 to 2018Configuration
In Million CNY. Margins, Growth Rates In %
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Revenue | - - | - - | - - | - - | 12.00 | 125.00 | |
|
EPS
|
-3.50 | -0.68 | -66.57 | -3.46 | -0.83 | -2.70 | |
| Diluted in mil. | -3.50 | -0.68 | -66.57 | -3.46 | -0.83 | -2.70 | |
|
Profit
|
- - | - - | - - | - - | 8.00 | 91.00 | |
| Gross Margin | - - | - - | - - | 57.41 | 63.69 | 72.67 | |
| Pre Tax | -991.00 | -214.00 | -5,658.00 | -1,008.00 | -247.00 | -844.00 | |
| Profit Margin | - - | - - | - - | -1,867,998.15 | -1,933.04 | -670.57 | |
| ETR | 87.06 | 9.81 | -0.42 | -0.48 | - - | -9.43 | |
| Net | -991.00 | -193.00 | -5,681.00 | -1,013.00 | -247.00 | -844.00 | |
| Profit Margin | - - | - - | - - | -1,876,916.67 | -1,933.11 | -670.57 | |
| EBITDA | -985.00 | -225.00 | -5,613.00 | -972.00 | -1,478.00 | -694.00 | |
| EBITDA Margin | - - | - - | - - | -1,801,442.59 | -11,559.04 | -551.80 | |
| Operating Income | -127.00 | -176.00 | -688.00 | -1,049.00 | -1,400.00 | -932.00 | |
| Operating Margin | - - | - - | - - | -1,943,096.30 | -10,945.90 | -740.67 | |
| Interest Income | - - | - - | 2.00 | 28.00 | 38.00 | 107.00 | |
| Loss | -126.00 | -198.00 | -687.00 | -1,049.00 | -1,412.00 | -957.00 | |
| Cost of Revenue | - - | - - | - - | - - | -4.00 | -34.00 | |
|
Operating Expenses
|
-126.00 | -198.00 | -687.00 | -1,049.00 | -1,408.00 | -923.00 | |
| R&D | -55.00 | -150.00 | -377.00 | -613.00 | -809.00 | -540.00 | |
| G&A | -26.00 | -34.00 | -277.00 | -242.00 | -276.00 | -165.00 | |
| SG&A | -26.00 | -34.00 | -311.00 | -440.00 | -603.00 | -396.00 | |
| S&M | - - | - - | -33.00 | -198.00 | -326.00 | -231.00 | |
| Depreciation and Amortization | -5.00 | -10.00 | -20.00 | -31.00 | -42.00 | -76.00 | |
| Interest Expenses | -1.00 | -2.00 | -23.00 | -4.00 | -5.00 | -23.00 | |
| Other Expenses | -864.00 | -38.00 | -4,969.00 | -40.00 | -1,152.00 | -6.00 | |
|
WA Shares Outstanding
|
283.00 | 283.00 | 85.00 | 293.00 | 297.00 | 313.00 | |
| Diluted | 283.00 | 283.00 | 85.00 | 293.00 | 297.00 | 313.00 |